Clinical evaluation for the effects of intraocular tissue plasminogen activator administration in various eye diseases

Clinical evaluation for the effects of intraocular tissue plasminogen activator administration in various eye diseases - Intraocular tissue plasminogen activator administration in various eye diseases

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000015726

Enrollment

Registered

2014-11-21

Start date

2010-01-25

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Various eye diseases

Interventions

Fibrin reaction caused by surgery and uveitis subretinal hematoma retinal vessel occlusive disease

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Fibrin reaction caused by surgery and uveitis, subretinal hematoma, retinal vessel occlusive disease

Exclusion criteria

Exclusion criteria: Medical history of hemorrhagic disorder

Design outcomes

Primary

Measure	Time frame
Improvements of visual acuity and effects of surgery	—

Countries

Japan

Contacts

Public ContactYASUYUKI TAKAI

Shimane University Faculty of Medicine Ophthalmology

takai611@med.shimane-u.ac.jp0853202284

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026